准确、简便且经济的检测方法用于诊断血友病A患者及携带者的F8基因倒位突变
血友病A最常见的突变是内含子22或内含子1基因倒位,二者共导致约50%的重型血友病A病例。本文报告一种基于RNA的简便准确检测方法,可在患者和杂合携带者中检测这些突变,无需专用设备或昂贵试剂,采用快速Bcl I和T4 DNA连接酶可在当天完成检测。
要点
- 基于RNA的逆转录巢式PCR可检测F8内含子22和内含子1倒位突变。
- 该方法无需专用设备或昂贵试剂,可标准化用于中心实验室检测。
- 使用快速Bcl I和T4 DNA连接酶可在同一天内准确检测F8倒位突变。
核心结论
- 基于RNA的检测方法可准确检测血友病A患者及杂合携带者的F8内含子22和内含子1倒位突变,且简便经济,可在同一天内完成检测。
研究设计与样本
- 本研究报告一种基于RNA的检测方法,从血液样本中纯化RNA,通过逆转录巢式PCR扩增F8序列片段,用于检测患者和杂合携带者的F8基因倒位突变。
主要发现
- 内含子22倒位检测扩增跨越外显子22至23剪接位点的F8序列,仅无内含子22倒位突变时扩增。
- 内含子1倒位检测扩增跨越外显子1至2剪接位点的F8序列,仅无内含子1倒位突变时扩增。
- 额外RT-NPCR反应扩增内含子22倒位序列(外显子19至内含子22内第一个框内终止密码子)或含F8外显子1与VBP1基因的嵌合转录本,分别仅由内含子22或内含子1倒位突变个体产生。
- 使用快速Bcl I和T4 DNA连接酶可在数分钟内完成DNA切割和连接,较先前需过夜孵育的方案显著改进。
关键数值与推荐
- 内含子22和内含子1基因倒位共导致约50%的重型血友病A病例。
- 如需进一步分类内含子22倒位突变(如1型或2型),可采用标准DNA-based「反向移位」PCR检测。
临床怎么用
- 该检测方法无需专用设备或昂贵试剂,可能提供有用且经济的方案,可标准化用于中心实验室检测。
- 这些方案可通过当天检测患者样本准确检测F8倒位突变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The most frequent mutations resulting in hemophilia A are an intron 22 or intron 1 gene inversion, which together cause ∼50% of severe hemophilia A cases. We report a simple and accurate RNA-based assay to detect these mutations in patients and heterozygous carriers. The assays do not require specialized equipment or expensive reagents; therefore, they may provide useful and economic protocols that could be standardized for central laboratory testing. RNA is purified from a blood sample, and reverse transcription nested polymerase chain reaction (RT-NPCR) reactions amplify DNA fragments with the F8 sequence spanning the exon 22 to 23 splice site (intron 22 inversion test) or the exon 1 to 2 splice site (intron 1 inversion test). These sequences will be amplified only from F8 RNA without an intron 22 or intron 1 inversion mutation, respectively. Additional RT-NPCR reactions are then carried out to amplify the inverted sequences extending from F8 exon 19 to the first in-frame stop codon within intron 22 or a chimeric transcript containing F8 exon 1 and the VBP1 gene. These latter 2 products are produced only by individuals with an intron 22 or intron 1 inversion mutation, respectively. The intron 22 inversion mutations may be further classified (eg, as type 1 or type 2, reflecting the specific homologous recombination sites) by the standard DNA-based "inverse-shifting" PCR assay if desired. Efficient Bcl I and T4 DNA ligase enzymes that cleave and ligate DNA in minutes were used, which is a substantial improvement over previous protocols that required overnight incubations. These protocols can accurately detect F8 inversion mutations via same-day testing of patient samples.
引用
- Dutta D, Gunasekera D, Ragni MV, et al. Accurate, simple, and inexpensive assays to diagnose F8 gene inversion mutations in hemophilia A patients and carriers. Blood Adv. 2016. PMID: 29296938. doi:10.1182/bloodadvances.2016001651
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。